Facebook icon Twitter icon
Exosomes/Microvesicles, June 4 – 8, 2018, Breckenridge, CO, USA
Extracellular vesicles (EVs) have emerged as critical mediators of intercellular communication in both local and distant microenvironments, during normal development and physiological processes, as well as in orchestrating systemic pathophysiological events. EVs comprise a large group of heterogeneous particles, including exosomes and microvesicles, and are released from virtually all cell types.

Differing in size, macromolecular composition and mechanism of formation, subpopulations of extracellular vesicles contain biologically active molecules, such as nucleic acids (DNA, mRNA, microRNA and other noncoding RNAs), proteins (transmembrane receptors, transcription factors, enzymes, extracellular matrix proteins) and lipids that can in part or in sum contribute to the functional capabilities of the vesicle itself, or the reprogramming of target cells that interact with EVs. This complexity presents significant challenges to determining the functional roles of the various EV populations during both normal and pathological processes.

This symposium will:
  • Deepen our understanding of the structural and functional complexity of extracellular vesicles, their biogenesis, cargo enrichment, potential as ideal biomarkers and breakthroughs in their use as therapeutic targets/agents;
  • Consider future directions of the field, including the identification of the most pressing unanswered questions, the areas needing more focus, and those that would benefit from new approaches and methodologies developed and used in other related fields;
  • Provide a forum for trainees and new investigators to learn about current work in the field, as well as foster collaborations and provide networking opportunities with established investigators and other professionals.

Hear the following confirmed invited speakers (additional short talk speakers will be selected from abstracts):
Gemma Kathleen Alderton, Science Magazine, UK
Xandra O. Breakefield, Massachusetts General Hospital, USA
Richard A. Cerione, Cornell University, USA
James Clancy, University of Notre Dame, USA
Bruno Costa-Silva, Champalimaud Foundation, Portugal
Olivier de Wever, University Hospital Ghent, Belgium
Dolores Di Vizio, Cedars-Sinai, USA
Marlene Dreux, CIRI, International Center for Infectology Research, France
Susanne Gabrielsson, Karolinska Institutet, Sweden
Stephen J. Gould, Johns Hopkins University School of Medicine, USA
Andrew Hill, La Trobe University, Australia
Tsuneya Ikezu, Boston University School of Medicine, USA
David Issadore, University of Pennsylvania, USA
Raghu Kalluri, University of Texas MD Anderson Cancer Center, USA
Jan Lötvall, University of Gothenburg, Sweden
David Lyden, Weill Cornell Medical College, USA
Stefan Momma, Frankfurt University Hospital, Germany
Takahiro Ochiya, National Cancer Center Research Institute, Japan
Janusz Rak, McGill University, Canada
Neta Regev-Rudzki, Weizmann Institute of Science, Israel
Eva Rohde, Paracelsus Medical University Salzburg, Austria
Jeff S. Schorey, University of Notre Dame, USA
Johan Skog, Exosome Diagnostics, Inc., USA
Philip D. Stahl, Washington University in St. Louis, School of Medicine, USA
Clotilde Théry, Institut Curie, France
Ana Claudia Torrecilhas, Universidade Federal de São Paulo, Brazil
Olga V. Volpert, University of Texas MD Anderson Cancer Center, USA
Marca H.M. Wauben, Universiteit Utrecht, Netherlands
Dihua Yu, University of Texas MD Anderson Cancer Center, USA
Alexia-Ileana Zaromytidou, Nature Cell Biology, UK
Huang-Ge Zhang, University of Louisville, USA

Additional short talk speakers will be added, chosen from abstracts.
June 4 – 8, 2018
Beaver Run Resort
Breckenridge, Colorado, USA

Scientific Organizers:
Crislyn D'Souza-Schorey, University of Notre Dame
David Lyden, Weill Cornell
Medical College
Submit Abstract Apply for Scholarship
Submit Abstract Submit Abstract
Register Register


• Extracellular Vesicles (EVs): Cargo and Composition

• EVs and Regulation of the Immune Response

• Panel: Meet the Editors

• EVs and Cancer I (Tumor Growth and Dissemination)

• EVs in Neurobiology: Neurodevelopment, Degeneration and Regeneration

• EVs and Cancer II (Metastases)

• Current and Emerging Technologies

• EVs in Host-Pathogen Interactions

• EV Therapeutics

• Plus two workshops


Scholarship Application:
February 6, 2018

Discounted Abstract Submission:
February 6, 2018

Abstract Submission:
March 6, 2018

Discounted Registration:
April 10, 2018
Who should attend?
Cancer Researchers • Cell Biologists • Drug Developers • Immunologists • Molecular Biologists • Neuroscientists

Additional Information
  • Click here to view the program and click here to download a program flyer.
  • Deadlines are at midnight US Mountain Time.
  • Discounted abstract submission and discounted registration save 50 USD and 200 USD, respectively, on later fees.
  • Presenting a poster is an excellent way to gain feedback on your work. Abstracts can be submitted through the discounted registration deadline for poster presentation, but those submitted by the abstract deadline will also be considered for short talk selection.
  • Please note that the first advertised meeting date is the date of arrival and registration, and the last date that of the last organized sessions.